The purpose of this study is to see if adding a regimen of individualized psychotherapy can
help bipolar I patients who are on lithium.
While having a manic or depressed episode patients will be assigned randomly (like tossing a
coin) to receive appropriate medication either with or without additional individual
psychotherapy. If a patient responds well, he/she will again be assigned randomly to receive
further preventative treatment in which medication will be managed either with continued
medication clinic visits alone or with additional individual psychotherapy (the patient may
not receive the same additional treatment this time). Patient response to treatment will be
evaluated throughout the study. If manic/depressive symptoms return at any point during the
study, the patient will be treated with appropriate medication and will continue the study.
An individual may be eligible for this study if he/she:
Has Bipolar I disorder, is experiencing a manic or depressed episode at the time of study
entry, and is at least 18 years old.
Drug Treatment for Alcoholics With Bipolar Disorder
Completed
University of Pittsburgh
Phase 2
2000-10-01
The purpose of this study is to test the effectiveness of sodium valproate (Depacon) in
treating individuals with alcohol dependence and comorbid bipolar disorder.
Drug Treatment for Alcoholics With Bipolar Disorder
Completed
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Phase 2
2000-10-01
The purpose of this study is to test the effectiveness of sodium valproate (Depacon) in
treating individuals with alcohol dependence and comorbid bipolar disorder.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
